Cencora | COR - Betriebsergebnis

Aktienkurs
257.71
Täglich Wechseln
-3.40 -1.30%
Monatlich
-20.06%
Jährlich
-11.20%
Q2 Prognose
252.53




Betriebsergebnis Veränderung Datum
Ambu A/S DKK 173M 9M 2026-03
Amplifon EUR 48.08M 23.79M 2025-12
Apollo Hospitals Enterprise Ltd INR 7.46B 228M 2025-12
Avanos Medical USD 8.9M 15.87M 2026-03
Brookdale Senior Living USD 27.38M 14.18M 2025-12
Cencora USD 1.02B 57.38M 2025-12
Coloplast 1.85B 102M 2025-12
Convatec Group USD 175.7M 101.1M 2024-12
Diasorin EUR 56M 8.57M 2026-03
Encompass Health USD 319.1M 35.7M 2026-03
Enovis USD 9.24M 6.8M 2026-03
GE HealthCare Technologies USD 878M 147M 2025-12
Gulf Medical Proj AED 30.8M 8.97M 2025-12
Hoya 73.65B 752M 2026-03
Med Life RON 40.09M 1.45M 2025-09
Oriola-kd EUR 5.4M 1.2M 2025-12
Pediatrix Medical Group USD 54.67M 19.33M 2025-12
Rede D'or Sao Luiz BRL 2.91B 350.85M 2026-03
Siemens Healthineers EUR 726M 49M 2026-03
Solventum Corp USD 85M 20M 2026-03
Sonova Holding CHF 296.8M 156.9M 2025-12
Supermax Corporation Bhd MYR -63.56M 79.6M 2025-12
Veradigm USD -45.47M 70.47M 2022-12
Zimmer Biomet Holdings USD 395.1M 92.2M 2026-03